| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/11/1994 | WO1994009811A1 An adhesion molecule |
| 05/11/1994 | WO1994009804A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/11/1994 | WO1994009803A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 05/11/1994 | WO1994009799A1 Anti-inflammatory factor, method of isolation, and use |
| 05/11/1994 | WO1994003620A3 Method of increasing expression of viral proteins |
| 05/11/1994 | EP0596725A2 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
| 05/11/1994 | EP0596459A2 Process for purifying recombinant proteins, and use of products thereof |
| 05/11/1994 | EP0596032A1 Induction of cytotoxic t-lymphocyte responses |
| 05/11/1994 | EP0596031A1 Neural calcium-activated neutral proteinase inhibitors |
| 05/11/1994 | EP0595970A1 Improved vaccine |
| 05/11/1994 | EP0595935A1 Papilloma virus vaccine |
| 05/11/1994 | EP0595873A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 05/11/1994 | EP0595855A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/11/1994 | EP0595838A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 05/11/1994 | EP0595822A1 Thyroidal receptor for n-acetylglucosamine |
| 05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
| 05/11/1994 | EP0489771B1 MODIFIED HUMAN ANTI-Rh(D) ANTIBODIES |
| 05/11/1994 | CA2448557A1 Multidrug resistance gene |
| 05/11/1994 | CA2148258A1 Transcription factor dp-1 |
| 05/11/1994 | CA2148244A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | CA2148007A1 Allergenic extracts |
| 05/11/1994 | CA2147877A1 Immunization against neisseria gonorrhoeae and neisseria meningitidis |
| 05/11/1994 | CA2147756A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
| 05/11/1994 | CA2147509A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | CA2147480A1 Cultured cells of quillaja sp. |
| 05/11/1994 | CA2146926A1 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
| 05/10/1994 | US5310958 Durg delivery, side effect reduction |
| 05/10/1994 | US5310893 Oligonucleotide probe |
| 05/10/1994 | US5310875 Antiallergens |
| 05/10/1994 | US5310678 Genetic engineering, poultry |
| 05/10/1994 | US5310671 Vector for foreign dna and sequence for regulating thegene; vaccines |
| 05/10/1994 | US5310668 Varicella-zoster virus as a live recombinant vaccine |
| 05/10/1994 | US5310654 Method for determining virulence of Yersinia |
| 05/10/1994 | US5310651 DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2 |
| 05/10/1994 | US5310551 Method for inhibiting pulmonary oxygen toxicity |
| 05/10/1994 | US5310535 Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| 05/06/1994 | CA2102256A1 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
| 05/06/1994 | CA2089630A1 Process for obtaining antibodies against human and animal immunoglobulins from the colostrum and milk for mammals immunized with the respective immunoglobulins |
| 05/04/1994 | EP0595743A1 Bihaptinic derivatives for binding for technetium or rhenium, process for their preparation, application for diagnosis and therapy, kits and immunological reactants comprising them |
| 05/04/1994 | EP0595638A2 Epitope-related peptides of human parvovirus |
| 05/04/1994 | EP0595436A2 Porcine respiratory and reproductive disease virus, vaccines and viral DNA |
| 05/04/1994 | EP0595188A2 Process for producing vaccine for a bacterial toxin belonging to the RTX toxin family |
| 05/04/1994 | EP0594950A1 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component |
| 05/04/1994 | EP0594881A1 Expression vectors and their application in the construction of HIV-resistant human cells for therapeutic uses |
| 05/04/1994 | EP0594803A1 Method for reducing side-effects of a drug |
| 05/04/1994 | EP0594764A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 05/04/1994 | EP0594743A1 Continuous cell line and vaccine against avian coccidia |
| 05/04/1994 | EP0594739A1 Cancer treatment |
| 05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
| 05/04/1994 | EP0594638A1 Peptides for use in induction of t cell activation against hiv-1 |
| 05/04/1994 | EP0594631A1 Bordetella bronchiseptica outer membrane antigen |
| 05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
| 05/04/1994 | EP0516655B1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
| 05/04/1994 | EP0439601B1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a distinct protein from this virus |
| 05/04/1994 | EP0413695B1 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3. |
| 05/04/1994 | EP0229046B1 Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
| 05/04/1994 | CN1086143A Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 05/04/1994 | CN1086142A Vaccines |
| 05/03/1994 | US5308752 Determination of antibody binding to dystrophin-protein complex |
| 05/03/1994 | US5308626 Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (ADCC) treatment of cancer and other diseases |
| 05/03/1994 | US5308614 Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones |
| 05/03/1994 | CA1329156C Immunoglobulin conjugates |
| 05/03/1994 | CA1329124C Conjugate malaria vaccine |
| 05/03/1994 | CA1329119C Cytotoxic therapy |
| 04/30/1994 | CA2109481A1 Anti-metastatic vaccine |
| 04/28/1994 | WO1994009368A1 Particles having gelatin-aminodextran coatings of and processes for making same |
| 04/28/1994 | WO1994009155A1 Methods of detecting alzheimer's disease |
| 04/28/1994 | WO1994009142A1 Vaccine containing a thiol protease |
| 04/28/1994 | WO1994009141A1 Genes that encode a surface protein of p. carinii |
| 04/28/1994 | WO1994009136A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/28/1994 | WO1994009132A1 Human cd26 and methods for use |
| 04/28/1994 | WO1994009131A1 Recombinant specific binding protein |
| 04/28/1994 | WO1994009116A1 Cho cells expressing human endothelin receptors |
| 04/28/1994 | WO1994009114A1 New bacterium causing poultry disease and vaccine derived thereof |
| 04/28/1994 | WO1994009038A1 Process for producing native intravenously administrable stabilised immunoglobin |
| 04/28/1994 | WO1994009035A1 New influenza virus peptides, diagnostics and vaccines |
| 04/28/1994 | WO1994009032A1 Methods and compositions for detecting anti-hepatitis e virus activity |
| 04/28/1994 | WO1994009023A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
| 04/28/1994 | WO1994009010A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 04/28/1994 | WO1994008621A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
| 04/28/1994 | WO1994008620A1 A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| 04/28/1994 | WO1994008619A1 Treatment of autoimmune and inflammatory disorders |
| 04/28/1994 | WO1994008617A1 O-derivatized alginic acid antigens |
| 04/28/1994 | WO1994008616A1 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008601A1 Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates |
| 04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
| 04/28/1994 | DE4244715A1 Isolation of circulating cancer cells from bloodstream |
| 04/28/1994 | DE4236069A1 Homeopathic medicaments for treating HIV infections - prepd. by dilution of infected serum |
| 04/28/1994 | DE4235718A1 New HIV-type immune deficiency virus ECACC V 92092318 |
| 04/28/1994 | CA2147622A1 Methods and compositions for detecting anti-hepatitis e virus activity |
| 04/28/1994 | CA2147378A1 Vaccine containing a thiol protease |
| 04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
| 04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
| 04/28/1994 | CA2147010A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
| 04/28/1994 | CA2146862A1 The taga gene and methods for detecting predisposition to peptic ulceration |